{{Drugbox
| Verifiedfields = 
| verifiedrevid = 
| IUPAC_name = 1-{4-[3-(4-Fluorophenoxy)phenyl]-3-butyn-2-yl}-1-hydroxyurea
| image = Fenleuton structure.png
| width = 200

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank =  
| ChemSpiderID_Ref = 
| ChemSpiderID = 65045
| UNII_Ref = 
| UNII = 
| KEGG_Ref = 
| KEGG = 
| ChEMBL_Ref = 
| ChEMBL =

<!--Chemical data-->
| C=17 | H=14 | O=3 | N=2 | F=1
| molecular_weight = 314.107 g/mol
| smiles = CC(C#Cc1cccc(c1)Oc2ccc(cc2)F)N(C(=O)N)O
| StdInChI_Ref = 
| StdInChI = InChI=1S/C17H15FN2O3/c1-12(20(22)17(19)21)5-6-13-3-2-4-16(11-13)23-15-9-7-14(18)8-10-15/h2-4,7-12,22H,1H3,(H2,19,21)
| StdInChIKey_Ref = 
| StdInChIKey = MWXPQCKCKPYBDR-UHFFFAOYSA-N<ref>{{cite web|url=http://www.chemspider.com/Chemical-Structure.65045.html|title=1-{4-[3-(4-Fluorophenoxy)phenyl]-3-butyn-2-yl}-1-hydroxyurea|author=|date=|work=chemspider.com|accessdate=24 December 2015}}</ref>
}}

'''Fenleuton''' acts as [[5-lipoxygenase]] [[enzyme inhibitor|inhibitor]] that inhibits [[leukotriene]] (LTB4, LTC4, LTD4, and LTE4) formation. It has been studied for potential use in [[veterinary medicine]] to treat [[respiratory disease]]s such as [[chronic obstructive pulmonary disease]] (COPD) in horses.<ref>{{cite journal | pmid = 9673966 |title=Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease | journal = J Vet Pharmacol Ther | date = 1998 | volume = 21 | issue = 3 | pages = 241â€“246 |vauthors=Marr KA, Lees P, Page CP, Cunningham FM | doi=10.1046/j.1365-2885.1998.00127.x}}</ref>

==References==
{{Reflist|2}}


{{Leukotrienergics}}

[[Category:Alkynes]]
[[Category:Leukotriene pathway inhibitors]]


{{pharmacology-stub}}